重新考虑心脏骤停后肌和状态的管理和预后影响
1Neuro-Intensive Care Unit, Department of Intensive Care, University Hospital of Geneva, Rue Gabrielle Perret Gentil 4, 1205 Geneva, Switzerland.
概括
在心脏骤停后,状态 (SE) 和肌肉是常见的. 量身定制的干预措施和标准化的EEG评估可以改善这些患者的治疗结果和预后.
科学领域:
- 神经学 神经学
- 临界护理医学 临界护理医学
- 神经生理学 神经生理学
背景情况:
- 在心脏骤停后的患者中,状态 (SE) 和肌经常发生.
- 这些神经学发现传统上与不良预后有关.
- 新出现的证据表明,定制干预措施可能会改善结果.
研究的目的:
- 批判性地评估定义,诊断挑战和SE和心脏骤停后肌细胞瘤的治疗策略.
- 强调在完善预后模型中需要标准化的EEG评估.
- 倡导对心脏骤停后脑病变管理采取细微的方法.
主要方法:
- 文献综述和对现有关于SE和心脏骤停后肌细胞结核的研究的批判性评估.
- 对诊断挑战和当前治疗策略的分析.
- 评估电脑电图 (EEG) 在预后和治疗指导中的作用.
主要成果:
- 在心脏骤停后,SE和肌是显著的神经并发症.
- 标准化的EEG评估对于准确的预后至关重要.
- 为了有效管理,EEG模式,演变和临床评估的结合是必要的.
结论:
- 结合EEG发现和临床评估的细微综合方法对于管理心脏骤停后脑病变至关重要.
- 需要采用EEG的精细预测模型.
- 以EEG为指导的积极的,定制的干预措施可能会改变患者的结果.
相关概念视频
Epilepsy and Seizures: Overview
1.6K
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
1.6K
Seizures: Classification
2.0K
Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
2.0K
Cardiopulmonary Resuscitation IV: Pharmacological Management
1.2K
Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
1.2K
Skeletal Muscle Relaxants: Adverse Effects
1.0K
Skeletal muscle relaxants are widely used for muscle paralysis and relieving pain following any muscle injury or stiffness. However, depending on the drug type, they can have adverse effects that range from mild to severe. Usually, nondepolarizing neuromuscular blockers have minimal side effects. For example, drugs like d-tubocurarine, cisatracurium, and rocuronium cause hypotension, whereas drugs like baclofen, when stopped abruptly, can lead to the recurrence of spastic conditions.
Unlike...
Unlike...
1.0K
Myocarditis III: Medical Management
309
Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
309
Dysrhythmias VI: Management of Dysrhythmias
577
Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...
577


